Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/8004
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-06-23T14:25:08Z-
dc.date.available2022-06-23T14:25:08Z-
dc.date.issued2017-09-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/8004-
dc.subjectAcesso aos Serviços de Saúdept_BR
dc.subjectHealth Services Accessibilitypt_BR
dc.subjectAccesibilidad a los Servicios de Saludpt_BR
dc.titleHC II implementa duplo check na administração de medicamentos de alto riscopt_BR
dc.title.alternativeInforme INCA 363pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 363

Files in This Item:
File Description SizeFormat 
Informe-INCA-2017-363-9-HC-II-implementa.pdf151.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.